People · Operator

Adam Boris

Named in public records as an officer, director or promoter · active 2015–2025 · Healthtech, Other Health Care

2
Companies
3
Filings
$7.3M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
My Diabetes Health, Inc.HealthtechSeries A$4.5M$15.7M2025
Conceivex IncOther Health CareSeed$2.9M$3.3M2015
Operator network

Adam Boris at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Neel Patel · 2 companies · 1 sharedNeel PatelPrem Sahasranam · 1 companies · 1 sharedPrem SahasranamRobert Brogan · 1 companies · 1 sharedRobert BroganCarol Lomas · 1 companies · 1 sharedCarol LomasDavid Madgy · 1 companies · 1 sharedDavid MadgyDennis Stepanovich · 1 companies · 1 sharedDennis StepanovichHarry Cendrowski · 1 companies · 1 sharedHarry CendrowskiJane Mary Kiernan · 1 companies · 1 sharedJane Mary KiernanJane Mary Sullivan · 1 companies · 1 sharedJane Mary SullivanKurt Kramarenko · 1 companies · 1 sharedKurt KramarenkoMichael La Vean · 1 companies · 1 sharedMichael La VeanMichael LaVean · 1 companies · 1 sharedMichael LaVeanRichard Kughn · 1 companies · 1 sharedRichard KughnMy Diabetes Health, Inc. · $4.5M raisedMy Diabetes Health, I…Conceivex Inc · $2.9M raisedConceivex IncAdam BorisAB
Adam Boris Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Adam Boris on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Neel Patel12
Michael La Vean11
Dennis Stepanovich11
Harry Cendrowski11
Kurt Kramarenko11
Carol Lomas11
Michael LaVean11
Prem Sahasranam11
Robert Brogan11
Jane Mary Sullivan11
Jane Mary Kiernan11
Richard Kughn11
David Madgy11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.